【4971】メック

電子基板用薬品。

類似企業：

【業界1位】三菱ケミカルグループ

【売上同水準】トリケミカル研究所 丸東産業

東証プライム

化学化学

＞

化学化学

売上高

営業利益

経常利益

当期利益

業績予想修正

対前回修正率

当初予想比較

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.12	2025/02/14	当初予	20,000	-	-	-	5,000	-	-	-	5,100	-	-	-	3,600	-	-	-
2024.12	2025/02/14	実	18,234	↓	-1.4%	+11.9%	4,562	↓	-6.9%	+52.1%	4,682	↓	-10.0%	+51.0%	2,291	↓	-36.4%	+6.6%
2024.12	2024/11/11	Q3予	18,500	→	0.0%	+13.5%	4,900	→	0.0%	+63.3%	5,200	→	0.0%	+67.7%	3,600	→	0.0%	+67.4%
2024.12	2024/08/08	Q2予	18,500	↑	+8.8%	+13.5%	4,900	↑	+34.2%	+63.3%	5,200	↑	+36.8%	+67.7%	3,600	↑	+35.8%	+67.4%
2024.12	2024/05/10	Q1予	17,000	↑	+4.3%	+4.3%	3,650	↑	+21.7%	+21.7%	3,800	↑	+22.6%	+22.6%	2,650	↑	+23.3%	+23.3%
2024.12	2024/02/14	当初予	16,300	-	-	-	3,000	-	-	-	3,100	-	-	-	2,150	-	-	-
2023.12	2024/02/14	実	14,020	↑	+1.6%	-6.5%	2,492	↑	+10.8%	-16.9%	2,683	↑	+7.3%	-13.5%	2,304	↑	+7.2%	+4.7%
2023.12	2023/11/10	Q3予	13,800	↑	+2.2%	-8.0%	2,250	↑	+25.0%	-25.0%	2,500	↑	+31.6%	-19.4%	2,150	↑	+24.3%	-2.3%
2023.12	2023/08/09	Q2予	13,500	→	0.0%	-10.0%	1,800	→	0.0%	-40.0%	1,900	→	0.0%	-38.7%	1,730	→	0.0%	-21.4%
2023.12	2023/05/23	修正予	13,500	→	0.0%	-10.0%	1,800	→	0.0%	-40.0%	1,900	→	0.0%	-38.7%	1,730	↑	+28.1%	-21.4%
2023.12	2023/05/10	Q1予	13,500	↓	-10.0%	-10.0%	1,800	↓	-40.0%	-40.0%	1,900	↓	-38.7%	-38.7%	1,350	↓	-38.6%	-38.6%
2023.12	2023/02/14	当初予	15,000	-	-	-	3,000	-	-	-	3,100	-	-	-	2,200	-	-	-
2022.12	2023/02/14	実	16,329	↓	-3.9%	-1.0%	4,004	↓	-9.0%	+0.1%	4,246	↓	-11.5%	+2.3%	3,064	↓	-9.9%	+2.1%
2022.12	2022/11/10	Q3予	17,000	→	0.0%	+3.0%	4,400	→	0.0%	+10.0%	4,800	→	0.0%	+15.7%	3,400	→	0.0%	+13.3%
2022.12	2022/08/10	Q2予	17,000	↑	+2.1%	+3.0%	4,400	↑	+4.8%	+10.0%	4,800	↑	+7.9%	+15.7%	3,400	↑	+6.3%	+13.3%
2022.12	2022/05/10	Q1予	16,650	↑	+0.9%	+0.9%	4,200	↑	+5.0%	+5.0%	4,450	↑	+7.2%	+7.2%	3,200	↑	+6.7%	+6.7%
2022.12	2022/02/14	当初予	16,500	-	-	-	4,000	-	-	-	4,150	-	-	-	3,000	-	-	-
2021.12	2022/02/14	実	15,038	↑	+3.0%	+17.5%	3,939	↑	+5.0%	+57.6%	4,104	↑	+6.6%	+64.2%	2,949	↑	+7.2%	+68.5%
2021.12	2021/11/10	Q3予	14,600	↑	+4.3%	+14.1%	3,750	↑	+7.1%	+50.0%	3,850	↑	+6.9%	+54.0%	2,750	↑	+5.8%	+57.1%
2021.12	2021/08/10	Q2予	14,000	↑	+2.9%	+9.4%	3,500	↑	+12.9%	+40.0%	3,600	↑	+12.5%	+44.0%	2,600	↑	+15.6%	+48.6%
2021.12	2021/05/12	Q1予	13,600	↑	+6.3%	+6.3%	3,100	↑	+24.0%	+24.0%	3,200	↑	+28.0%	+28.0%	2,250	↑	+28.6%	+28.6%
2021.12	2021/02/12	当初予	12,800	-	-	-	2,500	-	-	-	2,500	-	-	-	1,750	-	-	-
2020.12	2021/02/12	実	11,956	↑	+2.2%	+3.1%	2,370	↑	+3.0%	+39.4%	2,388	↑	+3.8%	+36.5%	1,595	↑	+6.3%	+27.6%
2020.12	2020/11/09	Q3予	11,700	↑	+5.4%	+0.9%	2,300	↑	+15.0%	+35.3%	2,300	↑	+15.0%	+31.4%	1,500	↑	+7.1%	+20.0%
2020.12	2020/08/11	Q2予	11,100	↓	-4.3%	-4.3%	2,000	↑	+17.6%	+17.6%	2,000	↑	+14.3%	+14.3%	1,400	↑	+12.0%	+12.0%
2020.12	2020/05/11	Q1予	11,600	→	0.0%	0.0%	1,700	→	0.0%	0.0%	1,750	→	0.0%	0.0%	1,250	→	0.0%	0.0%
2020.12	2020/02/13	当初予	11,600	-	-	-	1,700	-	-	-	1,750	-	-	-	1,250	-	-	-
2019.12	2020/02/13	実	10,865	↑	+1.5%	-7.9%	1,637	↑	+5.6%	-20.1%	1,722	↑	+7.6%	-18.0%	1,236	↑	+7.5%	-17.6%
2019.12	2019/11/11	Q3予	10,700	→	0.0%	-9.3%	1,550	→	0.0%	-24.4%	1,600	→	0.0%	-23.8%	1,150	→	0.0%	-23.3%
2019.12	2019/08/09	Q2予	10,700	→	0.0%	-9.3%	1,550	→	0.0%	-24.4%	1,600	→	0.0%	-23.8%	1,150	→	0.0%	-23.3%
2019.12	2019/08/07	修正予	10,700	↓	-9.3%	-9.3%	1,550	↓	-24.4%	-24.4%	1,600	↓	-23.8%	-23.8%	1,150	↓	-23.3%	-23.3%
2019.12	2019/05/10	Q1予	11,800	→	0.0%	0.0%	2,050	→	0.0%	0.0%	2,100	→	0.0%	0.0%	1,500	→	0.0%	0.0%
2019.12	2019/02/13	当初予	11,800	-	-	-	2,050	-	-	-	2,100	-	-	-	1,500	-	-	-
2018.12	2019/02/13	実	11,328	↓	-2.3%	-2.3%	2,222	↓	-3.4%	-3.4%	2,236	↓	-6.8%	-6.8%	1,778	↑	+1.6%	+1.6%
2018.12	2018/11/13	Q3予	11,600	→	0.0%	0.0%	2,300	→	0.0%	0.0%	2,400	→	0.0%	0.0%	1,750	→	0.0%	0.0%
2018.12	2018/08/09	Q2予	11,600	→	0.0%	0.0%	2,300	→	0.0%	0.0%	2,400	→	0.0%	0.0%	1,750	→	0.0%	0.0%
2018.12	2018/05/15	Q1予	11,600	→	0.0%	0.0%	2,300	→	0.0%	0.0%	2,400	→	0.0%	0.0%	1,750	→	0.0%	0.0%
2018.12	2018/02/13	FY予	11,600	-	-	-	2,300	-	-	-	2,400	-	-	-	1,750	-	-	-
2018.03	2017/05/10	当初予	8,600	-	-	-	1,100	-	-	-	1,200	-	-	-	850	-	-	-
2017.12	2018/02/13	実	9,641	↑	+4.8%	+7.1%	1,993	↑	+4.9%	+42.4%	2,063	↑	+5.8%	+37.5%	1,567	↑	+11.9%	+42.5%
2017.12	2017/11/02	Q2予	9,200	↑	+2.2%	+2.2%	1,900	↑	+35.7%	+35.7%	1,950	↑	+30.0%	+30.0%	1,400	↑	+27.3%	+27.3%
2017.12	2017/08/08	当初予	9,000	-	-	-	1,400	-	-	-	1,500	-	-	-	1,100	-	-	-
2017.03	2017/05/10	実	9,259	↑	+2.9%	+4.0%	1,887	↑	+4.8%	-5.6%	1,888	↑	+3.7%	-7.9%	1,642	↑	+13.2%	+13.2%
2017.03	2017/01/31	Q3予	9,000	↑	+1.1%	+1.1%	1,800	↓	-10.0%	-10.0%	1,820	↓	-11.2%	-11.2%	1,450	→	0.0%	0.0%
2017.03	2016/10/28	Q2予	8,900	→	0.0%	0.0%	2,000	→	0.0%	0.0%	2,050	→	0.0%	0.0%	1,450	→	0.0%	0.0%
2017.03	2016/07/29	Q1予	8,900	→	0.0%	0.0%	2,000	→	0.0%	0.0%	2,050	→	0.0%	0.0%	1,450	→	0.0%	0.0%
2017.03	2016/05/10	当初予	8,900	-	-	-	2,000	-	-	-	2,050	-	-	-	1,450	-	-	-
2016.03	2016/05/10	実	9,078	↑	+0.9%	-3.6%	2,185	↑	+4.0%	+1.6%	2,207	↑	+2.7%	+0.3%	1,514	↑	+4.4%	+4.4%
2016.03	2016/01/29	修正予	9,000	↓	-4.5%	-4.5%	2,100	↓	-2.3%	-2.3%	2,150	↓	-2.3%	-2.3%	1,450	→	0.0%	0.0%
2016.03	2015/10/30	Q2予	9,420	→	0.0%	0.0%	2,150	→	0.0%	0.0%	2,200	→	0.0%	0.0%	1,450	→	0.0%	0.0%
2016.03	2015/07/31	Q1予	9,420	→	0.0%	0.0%	2,150	→	0.0%	0.0%	2,200	→	0.0%	0.0%	1,450	→	0.0%	0.0%
2016.03	2015/05/08	当初予	9,420	-	-	-	2,150	-	-	-	2,200	-	-	-	1,450	-	-	-
2015.03	2015/05/08	実	9,057	↑	+1.8%	+9.1%	2,008	↑	+5.7%	+33.9%	2,129	↑	+6.5%	+36.5%	1,344	↑	+12.0%	+34.4%
2015.03	2015/01/30	Q3予	8,900	↑	+1.1%	+7.2%	1,900	↑	+8.6%	+26.7%	2,000	↑	+14.3%	+28.2%	1,200	↑	+9.1%	+20.0%
2015.03	2014/10/31	Q2予	8,800	→	0.0%	+6.0%	1,750	→	0.0%	+16.7%	1,750	→	0.0%	+12.2%	1,100	→	0.0%	+10.0%
2015.03	2014/07/31	Q1予	8,800	↑	+6.0%	+6.0%	1,750	↑	+16.7%	+16.7%	1,750	↑	+12.2%	+12.2%	1,100	↑	+10.0%	+10.0%
2015.03	2014/05/09	当初予	8,300	-	-	-	1,500	-	-	-	1,560	-	-	-	1,000	-	-	-
2014.03	2014/05/09	実	8,003	↑	+2.6%	+2.6%	1,421	↑	+9.3%	+9.3%	1,551	↑	+7.0%	+7.0%	925	↓	-7.5%	-7.5%
2014.03	2014/01/31	当初予	7,800	-	-	-	1,300	-	-	-	1,450	-	-	-	1,000	-	-	-

【4971】メック 電子基板用薬品。 類似企業： 【業界1位】 三菱ケミカルグループ 【売上同水準】 トリケミカル研究所 丸東産業

【4971】メック

電子基板用薬品。

類似企業：

【業界1位】三菱ケミカルグループ

【売上同水準】トリケミカル研究所丸東産業